CTi Biopharma Corp (NASDAQ:CTIC)

1.98
Delayed Data
As of Jul 02
 -0.04 / -1.98%
Today’s Change
1.65
Today|||52-Week Range
3.06
-16.10%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 4.50, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +127.27% increase from the last price of 1.98.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$5.9M
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
 
 
 
 
 
 
Growthannually 45.77%
 
 
 
 
 
 

Sales

Growthquarterly 117.96%
 
 
 
 
 
 
Growthannually -10.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account